Clinical development of medicinal products intended for the treatment of pain

  • Email
  • Help
Current version

Adopted guideline


Reference numberEMA/CHMP/970057/2011
Effective from01/07/2017 
KeywordsPain, neuropathic, nociceptive, chronic, acute, analgesia
DescriptionThis guideline is intended to provide guidance on the clinical development of new medicinal products for the treatment of pain. It replaces and updates the separate guidelines on neuropathic and nociceptive pain (superseeded documents below).

Document history

First version

Current version

Adopted guideline


Draft guideline - Corr. 1

Draft guideline

Concept paper

In operation: 01/07/2017-present


Published: 21/12/2015

Published: 30/05/2013

Published: 29/09/2011

Document to be superseded

Adopted guideline

Overview of comments

Draft guideline

In operation: 31/06/2007–present

Published: 24/01/2007

Published: 26/01/2006

Document to be supersededAdopted guidelineIn operation: 01/05/2003–present

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more